Skip to main content
SpringerLink
Log in

Treating Erectile Dysfunctions

  • Chapter
  • First Online:
The Diagnosis and Treatment of Male Infertility

  • 857 Accesses

Abstract

Erectile dysfunction (ED) is defined as the persistent inability to attain or maintain penile erection sufficient for satisfactory sexual performance. Despite its benign nature, ED may affect the physical and psychosocial well-being of sufferers, causing a significant impact on their quality of life (QoL). Recent evidence has pondered ED as an early manifestation of cardiovascular disease suggesting that its occurrence should not be dealt with as only a QoL issue, but also as a potential warning sign of a more serious medical condition. With an increasing knowledge about possible disturbances of penile erection, new organically oriented therapeutic options have been developed, which have revolutionized the treatment of ED. Through the use of clinical scenarios, this chapter reviews the available approaches for the evaluation and management of patients presenting with ED.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. Chapter 1: The management of erectile dysfunction: an AUA update. J Urol. 2005 Jul;174(1):230–9.

    Google Scholar 

  2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994;151(1):54–61.

    CAS  PubMed  Google Scholar 

  3. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50–6.

    Article  CAS  PubMed  Google Scholar 

  4. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58(13):1378–85.

    Article  PubMed  Google Scholar 

  5. Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010;64(7):848–57.

    Article  CAS  PubMed  Google Scholar 

  6. Stoleru S, Redoute J, Costes N, Lavenne F, Bars DL, Dechaud H, et al. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder. Psychiatry Res. 2003;124(2):67–86.

    Article  PubMed  Google Scholar 

  7. Dean RC, Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am. 2005 Nov;32(4):379–95.

    Google Scholar 

  8. Milhoua P, Lowe D, Melman A. Chapter 1: Normal anatomy and physiology. In: Mulcahy JJ, editor. Male sexual function: a guide to clinical management. 2nd ed. New Jersey, USA: Humana Press Inc.; 2006.

    Google Scholar 

  9. Lizza EF, Rosen RC. Definition and classification of erectile dysfunction: report of the nomenclature committee of the international society of impotence research. Int J Impot Res. 1999;11(3):141–3.

    Article  CAS  PubMed  Google Scholar 

  10. Rosen MP, Greenfield AJ, Walker TG, Grant P, Guben JK, Dubrow J, et al. Arteriogenic impotence: findings in 195 impotent men examined with selective internal pudendal angiography. Young investigator’s award. Radiology. 1990;174(3 Pt 2):1043–8.

    Article  CAS  PubMed  Google Scholar 

  11. Sullivan ME, Thompson CS, Dashwood MR, Khan MA, Jeremy JY, Morgan RJ, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res. 1999;43(3):658–65.

    Article  CAS  PubMed  Google Scholar 

  12. Abicht J. Testing the autonomic system. In: Jonas U, Thoh W, Steif C, editors. Berlin, Germany: Springer; 1991. p. 187–94.

    Google Scholar 

  13. Mulligan T, Schmitt B. Testosterone for erectile failure. J Gen Intern Med. 1993;8(9):517–21.

    Article  CAS  PubMed  Google Scholar 

  14. Mikhail N. Does testosterone have a role in erectile function? Am J Med. 2006;119(5):373–82.

    Article  CAS  PubMed  Google Scholar 

  15. Masters W, Johnson V. Human sexual response. Boston: Little Brown; 1970.

    Google Scholar 

  16. Kim SC, Oh MM. Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence. J Urol. 1992;147(6):1530–2.

    CAS  PubMed  Google Scholar 

  17. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–30.

    Article  CAS  PubMed  Google Scholar 

  18. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319–26.

    Article  CAS  PubMed  Google Scholar 

  19. Rosen RC, Fisher WA, Beneke M, Homering M, Evers T. The couples-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment. BJU Int. 2007;99(4):849–59.

    Article  PubMed  Google Scholar 

  20. Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572–88.

    Article  PubMed  Google Scholar 

  21. Canadian Diabetes Association Clinical Practice Guidelines Expert C, Brock G, Harper W. Erectile dysfunction. Can J Diabetes. 2013 Apr;37 Suppl 1:S150–2.

    Google Scholar 

  22. Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, et al. The princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766–78.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Levine LA, Carroll RA. Nocturnal penile tumescence and rigidity in men without complaints of erectile dysfunction using a new quantitative analysis software. J Urol. 1994;152(4):1103–7.

    CAS  PubMed  Google Scholar 

  24. Velcek D, Evans JA. Cavernosography. Radiology. 1982;144(4):781–5.

    Article  CAS  PubMed  Google Scholar 

  25. Lue TF. Erectile dysfunction. N Engl J Med. 2000;342(24):1802–13.

    Article  CAS  PubMed  Google Scholar 

  26. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil study group. N Engl J Med. 1998;338(20):1397–404.

    Article  CAS  PubMed  Google Scholar 

  27. Padma-Nathan H, Steers WD, Wicker PA. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil study group. Int J Clin Pract. 1998;52(6):375–9.

    CAS  PubMed  Google Scholar 

  28. Levinson IP, Khalaf IM, Shaeer KZ, Smart DO. Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa. Int J Impot Res. 2003;15(Suppl 1):S25–9.

    Article  CAS  PubMed  Google Scholar 

  29. Stuckey BG, Jadzinsky MN, Murphy LJ, Montorsi F, Kadioglu A, Fraige F, et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diab Care. 2003;26(2):279–84.

    Article  CAS  Google Scholar 

  30. Olsson AM, Persson CA, Swedish sildenafil investigators G. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease. Int J Clin Pract. 2001 Apr;55(3):171–6.

    Google Scholar 

  31. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332–6.

    Article  CAS  PubMed  Google Scholar 

  32. Montorsi F, Verheyden B, Meuleman E, Junemann KP, Moncada I, Valiquette L, et al. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol. 2004 Mar;45(3):339–44; discussion 344–35.

    Google Scholar 

  33. McMahon C. Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. J Sex Med. 2005 May;2(3):415–25; discussion 425–17.

    Google Scholar 

  34. Roehrborn CG, Kaminetsky JC, Auerbach SM, Montelongo RM, Elion-Mboussa A, Viktrup L. Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once-daily tadalafil treatment. BJU Int. 2010;105(4):502–7.

    Article  CAS  PubMed  Google Scholar 

  35. Oelke M, Giuliano F, Mirone V, Xu L, Cox D, Viktrup L. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917–25.

    Article  CAS  PubMed  Google Scholar 

  36. Porst H, Oelke M, Goldfischer ER, Cox D, Watts S, Dey D, et al. Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies. Urology. 2013;82(3):667–73.

    Article  PubMed  Google Scholar 

  37. Bischoff E, Schneider K. A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection. Int J Impot Res. 2001;13(4):230–5.

    Article  CAS  PubMed  Google Scholar 

  38. Choi S, O’Connell L, Min K, Kim NN, Munarriz R, Goldstein I, et al. Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model. J Androl. 2002 May-Jun;23(3):332–7.

    Google Scholar 

  39. Moore RA, Derry S, McQuay HJ. Indirect comparison of interventions using published randomised trials: systematic review of pde-5 inhibitors for erectile dysfunction. BMC Urol. 2005;5:18.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192–9.

    Article  CAS  PubMed  Google Scholar 

  41. Sperling H, Gittelman M, Norenberg C, Ulbrich E, Ewald S. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials. J Sex Med. 2011;8(1):261–71.

    Article  CAS  PubMed  Google Scholar 

  42. Sperling H, Debruyne F, Boermans A, Beneke M, Ulbrich E, Ewald S. The potent i randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. J Sex Med. 2010;7(4 Pt 1):1497–507.

    Article  CAS  PubMed  Google Scholar 

  43. Debruyne FM, Gittelman M, Sperling H, Borner M, Beneke M. Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations. J Sex Med. 2011;8(10):2912–23.

    Article  CAS  PubMed  Google Scholar 

  44. Gittelman M, McMahon CG, Rodriguez-Rivera JA, Beneke M, Ulbrich E, Ewald S. The potent ii randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. Int J Clin Pract. 2010;64(5):594–603.

    Article  CAS  PubMed  Google Scholar 

  45. Kyle JA, Brown DA, Hill JK. Avanafil for erectile dysfunction. Ann Pharmacother. 2013;47(10):1312–20.

    Article  CAS  PubMed  Google Scholar 

  46. Cui YS, Li N, Zong HT, Yan HL, Zhang Y. Avanafil for male erectile dysfunction: a systematic review and meta-analysis. Asian J Androl. 2014 May-Jun;16(3):472–7.

    Google Scholar 

  47. Makhlouf A, Kshirsagar A, Niederberger C. Phosphodiesterase 11: a brief review of structure, expression and function. Int J Impot Res. 2006 Nov-Dec;18(6):501–9.

    Google Scholar 

  48. Thadani U, Smith W, Nash S, Bittar N, Glasser S, Narayan P, et al. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002;40(11):2006–12.

    Article  CAS  PubMed  Google Scholar 

  49. Kloner RA. Novel phosphodiesterase type 5 inhibitors: assessing hemodynamic effects and safety parameters. Clin Cardiol. 2004;27(4 Suppl 1):I20–5.

    Article  PubMed  Google Scholar 

  50. Kloner RA, Jackson G, Emmick JT, Mitchell MI, Bedding A, Warner MR, et al. Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol. 2004;172(5 Pt 1):1935–40.

    Article  PubMed  Google Scholar 

  51. Auerbach SM, Gittelman M, Mazzu A, Cihon F, Sundaresan P, White WB. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. Urology. 2004 Nov;64(5):998–1003; discussion 1003–4.

    Google Scholar 

  52. Gruenwald I, Shenfeld O, Chen J, Raviv G, Richter S, Cohen A, et al. Positive effect of counseling and dose adjustment in patients with erectile dysfunction who failed treatment with sildenafil. Eur Urol. 2006;50(1):134–40.

    Article  PubMed  Google Scholar 

  53. Hatzimouratidis K, Moysidis K, Bekos A, Tsimtsiou Z, Ioannidis E, Hatzichristou D. Treatment strategy for “non-responders” to tadalafil and vardenafil: a real-life study. Eur Urol. 2006 Jul;50(1):126–32; discussion 132–23.

    Google Scholar 

  54. Hatzichristou D, Moysidis K, Apostolidis A, Bekos A, Tzortzis V, Hatzimouratidis K, et al. Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders. Eur Urol. 2005 Apr;47(4):518–22; discussion 522–13.

    Google Scholar 

  55. Oakley N, Moore KT. Vacuum devices in erectile dysfunction: indications and efficacy. Br J Urol. 1998;82(5):673–81.

    Article  CAS  PubMed  Google Scholar 

  56. Lewis RW, Witherington R. External vacuum therapy for erectile dysfunction: use and results. World J Urol. 1997;15(1):78–82.

    Article  CAS  PubMed  Google Scholar 

  57. Nadig PW, Ware JC, Blumoff R. Noninvasive device to produce and maintain an erection-like state. Urology. 1986;27(2):126–31.

    Article  CAS  PubMed  Google Scholar 

  58. El-Bahrawy M, El-Baz MA, Emam A, El-Magd MA. Noninvasive vacuum constriction device in the management of erectile dysfunction. Int Urol Nephrol. 1995;27(3):331–3.

    Google Scholar 

  59. Tan HL. Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. Pharmacoeconomics. 2000;17(1):77–107.

    Article  CAS  PubMed  Google Scholar 

  60. Chen J, Mabjeesh NJ, Greenstein A. Sildenafil versus the vacuum erection device: patient preference. J Urol. 2001;166(5):1779–81.

    Article  CAS  PubMed  Google Scholar 

  61. Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am. 2001 May;28(2):335–341, ix–x.

    Google Scholar 

  62. Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G. Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol. 1995;75(6):786–91.

    Article  CAS  PubMed  Google Scholar 

  63. Cookson MS, Nadig PW. Long-term results with vacuum constriction device. J Urol. 1993;149(2):290–4.

    CAS  PubMed  Google Scholar 

  64. Limoge JP, Olins E, Henderson D, Donatucci CF. Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: a study of satisfaction and safety. J Urol. 1996;155(4):1276–9.

    Article  CAS  PubMed  Google Scholar 

  65. Carson CC 3rd. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol. 2004;171(4):1611–4.

    Article  PubMed  Google Scholar 

  66. Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010;58(2):243–8.

    Article  PubMed  Google Scholar 

  67. Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012;187(5):1769–75.

    Article  PubMed  Google Scholar 

  68. Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy—a novel effective treatment for erectile dysfunction in severe ed patients who respond poorly to pde5 inhibitor therapy. J Sex Med. 2012 Jan;9(1):259–64.

    Google Scholar 

  69. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet. 1982;2(8304):938.

    Article  CAS  PubMed  Google Scholar 

  70. Brindley GS. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatry. 1983;143:332–7.

    Article  CAS  PubMed  Google Scholar 

  71. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804–14.

    Article  PubMed  Google Scholar 

  72. Leungwattanakij S, Flynn V Jr, Hellstrom WJ. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am. 2001;28(2):343–54.

    Article  CAS  PubMed  Google Scholar 

  73. Ruiz Rubio JL, Hernandez M, Rivera de los Arcos L, Martinez AC, Garcia-Sacristan A, Prieto D. Mechanisms of prostaglandin e1-induced relaxation in penile resistance arteries. J Urol. 2004 Feb;171(2 Pt 1):968–73.

    Google Scholar 

  74. Robertson D, Biaggioni I. Chapter 10. Adrenoceptor antagonist drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic & clinical pharmacology. 12 ed. New York: McGraw-Hill; 2012..

    Google Scholar 

  75. Anonymous. Caverject-alprostadil injection, powder, lyophilized, for solution In: LLC PaUC, editor. 2016.

    Google Scholar 

  76. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The alprostadil study group. N Engl J Med. 1996;334(14):873–7.

    Article  CAS  PubMed  Google Scholar 

  77. McMahon C. A comparison of the response to the intracavernosal injection of papaverine and phentolamine, prostaglandin e1 and a combination of all three agents in the management of impotence. Int J Impot Res. 1991;146(6):1564–5.

    Google Scholar 

  78. Sundaram CP, Thomas W, Pryor LE, Sidi AA, Billups K, Pryor JL. Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology. 1997;49(6):932–5.

    Article  CAS  PubMed  Google Scholar 

  79. Vardi Y, Sprecher E, Gruenwald I. Logistic regression and survival analysis of 450 impotent patients treated with injection therapy: long-term dropout parameters. J Urol. 2000;163(2):467–70.

    Article  CAS  PubMed  Google Scholar 

  80. Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated urethral system for erection (muse) study group. N Engl J Med. 1997;336(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  81. Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB, Kadesky KT, et al. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol. 1998;160(6 Pt 1):2041–6.

    Article  CAS  PubMed  Google Scholar 

  82. Mulhall JP, Jahoda AE, Ahmed A, Parker M. Analysis of the consistency of intraurethral prostaglandin e(1) (muse) during at-home use. Urology. 2001;58(2):262–6.

    Article  CAS  PubMed  Google Scholar 

  83. Montague DK. Penile prosthesis implantation in the era of medical treatment for erectile dysfunction. Urol Clin North Am. 2011;38(2):217–25.

    Article  PubMed  Google Scholar 

  84. Montague DK, Angermeier KW. Contemporary aspects of penile prosthesis implantation. Urol Int. 2003;70(2):141–6.

    Article  PubMed  Google Scholar 

  85. Mulcahy JJ, Austoni E, Barada JH, Choi HK, Hellstrom WJ, Krishnamurti S, et al. The penile implant for erectile dysfunction. J Sex Med. 2004;1(1):98–109.

    Article  PubMed  Google Scholar 

  86. Mulhall JP, Ahmed A, Branch J, Parker M. Serial assessment of efficacy and satisfaction profiles following penile prosthesis surgery. J Urol. 2003;169(4):1429–33.

    Article  PubMed  Google Scholar 

  87. Montorsi F, Rigatti P, Carmignani G, Corbu C, Campo B, Ordesi G, et al. Ams three-piece inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients. Eur Urol. 2000;37(1):50–5.

    Article  CAS  PubMed  Google Scholar 

  88. Holloway FB, Farah RN. Intermediate term assessment of the reliability, function and patient satisfaction with the ams700 ultrex penile prosthesis. J Urol. 1997;157(5):1687–91.

    Article  CAS  PubMed  Google Scholar 

  89. Tefilli MV, Dubocq F, Rajpurkar A, Gheiler EL, Tiguert R, Barton C, et al. Assessment of psychosexual adjustment after insertion of inflatable penile prosthesis. Urology. 1998;52(6):1106–12.

    Article  CAS  PubMed  Google Scholar 

  90. Carson CC, Mulcahy JJ, Govier FE. Efficacy, safety and patient satisfaction outcomes of the ams 700cx inflatable penile prosthesis: results of a long-term multicenter study. Ams 700cx study group. J Urol. 2000;164(2):376–80.

    Article  CAS  PubMed  Google Scholar 

  91. Mulcahy JJ. Long-term experience with salvage of infected penile implants. J Urol. 2000;163(2):481–2.

    Article  CAS  PubMed  Google Scholar 

  92. Ji YS, Ko YH, Song PH, Moon KH. Long-term survival and patient satisfaction with inflatable penile prosthesis for the treatment of erectile dysfunction. Korean J Urol. 2015;56(6):461–5.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Wilson SK, Cleves MA, Delk JR. Comparison of mechanical reliability of original and enhanced mentor alpha I penile prosthesis. J Urol. 1999;162(3 Pt 1):715–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH, 44195, USA

    Ahmad Majzoub

  2. Department of Urology, Hamad Medical Corporation, Hamad General Hospital, P.O. Box 3050, Doha, Qatar

    Haitham El Bardisi

  3. Department of Andrology, Cairo University Hospital, Kasr AlAini Hospital, AlManial, Cairo, Egypt

    Mohamed Arafa

Authors
  1. Ahmad Majzoub
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haitham El Bardisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed Arafa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmad Majzoub .

Editor information

Editors and Affiliations

  1. Liverpool Women's Hospital, Liverpool, United Kingdom

    Nabil Aziz

  2. Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio, USA

    Ashok Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Majzoub, A., El Bardisi, H., Arafa, M. (2017). Treating Erectile Dysfunctions. In: Aziz, N., Agarwal, A. (eds) The Diagnosis and Treatment of Male Infertility. Springer, Cham. https://doi.org/10.1007/978-3-319-56547-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56547-7_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56545-3

  • Online ISBN: 978-3-319-56547-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation